Literature DB >> 2021968

Serum-sickness-like illness as a complication after streptokinase therapy for acute myocardial infarction.

D H Schweitzer1, E E van der Wall, H A Bosker, E Scheffer, J D Macfarlane.   

Abstract

We report a case of serum-sickness-like illness in a 47-year-old patient who received early high-dose intravenous and intracoronary streptokinase following acute myocardial infarction. The picture comprised severe arthralgias, fever, an urticarial rash and marked elevation of circulating immune complexes. This case represents a rare complication of streptokinase therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2021968     DOI: 10.1159/000174768

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  3 in total

Review 1.  Drug-induced uveitis. Incidence, prevention and treatment.

Authors:  F W Fraunfelder; J T Rosenbaum
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

2.  Iritis after treatment with streptokinase.

Authors:  M Y Gray; J H Lazarus
Journal:  BMJ       Date:  1994-07-09

3.  Profiling the immune responses of human patients treated with recombinant streptokinase after myocardial infarct.

Authors:  O Reyes; I Torrens; A G Ojalvo; A Seralena; H E Garay
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.